The endocannabinoids present a rich system of central cannabinoid (CB1), peripheral cannabinoid (CB2), and non-CB receptor-mediated pharmacology that has stimulated research in many fields including memory, weight loss and appetite, neurodegeneration, tumor surveillance, analgesia, and inflammation.HU-211 cannabinoid,hu-210,dexanabinol buy,hu-211 jwh-018 and jwh-073,hu 243,hu-210 powder,hu-210 reddit.
Dexanabinol (HU-211 or ETS2101) is a synthetic cannabinoid derivative in development by e-Therapeutics plc. It is the “unnatural” enantiomer of the potent cannabinoid agonist HU-210.
Unlike other cannabinoid derivatives, HU-211 does not act as a cannabinoid receptor agonist, but instead has NMDA antagonist effects.
It therefore does not produce cannabis-like effects, but is anticonvulsant and neuroprotective, and is widely used in scientific research as well as currently being studied for applications such as treating head injury, stroke, or cancer.
It was shown to be safe in clinical trials and is currently undergoing Phase I trials for the treatment of brain cancer and advanced solid tumors.
It a synthetic terpene-based cannabinoid devoid of central cannabinoid (CB1) and peripheral cannabinoid (CB2) agonist activity, thus lacking the psychomotor responses characteristic of Δ9–THC. HU-211 does exhibit the neuroprotective, antioxidant properties of other related compounds like cannabidiol.
HU-211 cannabinoid,hu-210,dexanabinol buy,hu-211 jwh-018 and jwh-073,hu 243,hu-210 powder,hu-210 reddit
It also has anti-inflammatory properties derived through inhibition of NF-κB and the resulting decreases in cytokines such as TNFα and interleukin-6. HU-331
A crystalline solid
Shipping & Storage Information
Room Temperature in continental US; may vary elsewhere